Inventor
GARDINIER KEVIN MATTHEW
US15 patents
⚠️ This page may combine multiple inventors who share the name “GARDINIER KEVIN MATTHEW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LILLY CO ELI
8 patentsUS7320994B2Jan 22, 2008
Triazole derivatives as tachykinin receptor antagonists
LILLY CO ELI28 citations90
US7179804B2Feb 20, 2007
Tachykinin receptor antagonists
LILLY CO ELI30 citations90
US7595339B2Sep 29, 2009
CB1 modulator compounds
LILLY CO ELI6 citations70
US7902356B2Mar 8, 2011
Thiazolopyridinone derivates as MCH receptor antagonists
LILLY CO ELI6 citations57
US7276516B2Oct 2, 2007
CB1 antagonist compounds
LILLY CO ELI5 citations57
US8049013B2Nov 1, 2011
5- [4-(azetidin-3-yloxy)-phenyl]-2-phenyl-5H-thiazolo[5,4-C] pyridin-4-one derivatives and their use as MCH receptor antagonists
LILLY CO ELI0 citations38
US9469632B2Oct 18, 2016
6-substituted-3H-1,3-benzothiazol-2-one compounds as TARP-gamma 8 dependent AMPA receptor antagonists
LILLY CO ELI0 citations37
US7838543B2Nov 23, 2010
MCH receptor antagonists
LILLY CO ELI0 citations33
NOVARTIS AG
4 patentsUS11548865B2Jan 10, 2023
2-azaspiro[3.4]octane derivatives as M4 agonists
NOVARTIS AG2 citations70
US11485742B2Nov 1, 2022
2-azaspiro[3.4]octane derivatives as M4 agonists
NOVARTIS AG2 citations70
US12122761B2Oct 22, 2024
2-azaspiro[3.4]octane derivatives as M4 agonists
NOVARTIS AG0 citations59
US11820778B2Nov 21, 2023
2-azaspiro[3.4]octane derivatives as M4 agonists
NOVARTIS AG0 citations59